Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


HIV regimen
Apr 15, 2012

I recently switched from a regimen of Prezista, Norvir and Truvada to Prezista, Norvir and Isentress. This was due to some issues after a bone density test and lower than normal levels of phosphorous. It was a pre-emptive type of switch. Any comments on the regimen of Prezista, Norvir and Isentress would be much appreciated.

Q

Response from Dr. Young

Hello Q and thanks for posting.

Your new regimen is a bit unorthodox, being 2 fully active regimens, as opposed to the typically recommended 3), but in someone without drug resistance, I'd expect it to be fully active and very well tolerated. Because of the potency of the boosted PI Prezista, I'd not expect the same requirement for a third medication. Certainly, the switch from Truvada to Isentress (raltegravir) should ovoid risk of bone or kidney issues that are at times associated with tenofovir (part of Truvada).

Be well, BY



Previous
HIV
Next
Aspen Lamzid and Rabies PEP

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement